Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
Solventum Reports First Quarter 2024 Financial Results and Capital[...]
NCR Voyix Independent Chair James G. Kelly Becomes Executive Chair -[...]
04/18/2024 | Press release | Distributed by Public on 04/18/2024 08:43
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact